APA

Brown A. J., Precious H. M., Whitcomb J. M., Wong J. K., Quigg M., Huang W., Daar E. S., D'Aquila R. T., Keiser P. H., Connick E., Hellmann N. S., Petropoulos C. J., Richman D. D. & Little S. J. (20001121). Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. : Journal of virology.

Chicago

Brown A J, Precious H M, Whitcomb J M, Wong J K, Quigg M, Huang W, Daar E S, D'Aquila R T, Keiser P H, Connick E, Hellmann N S, Petropoulos C J, Richman D D and Little S J. 20001121. Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. : Journal of virology.

Harvard

Brown A. J., Precious H. M., Whitcomb J. M., Wong J. K., Quigg M., Huang W., Daar E. S., D'Aquila R. T., Keiser P. H., Connick E., Hellmann N. S., Petropoulos C. J., Richman D. D. and Little S. J. (20001121). Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. : Journal of virology.

MLA

Brown A J, Precious H M, Whitcomb J M, Wong J K, Quigg M, Huang W, Daar E S, D'Aquila R T, Keiser P H, Connick E, Hellmann N S, Petropoulos C J, Richman D D and Little S J. Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. : Journal of virology. 20001121.